"Impact of a Programme to Improve Interaction Among Professionals on the Management of Task Interruptions" (IMPACTT)

December 20, 2018 updated by: Nantes University Hospital

In 2017, all IMPACTT investigators experimented in coordinated manner on multifacet intervention program, proposed by the present research protocol, with 2 teams from healthcare units from the PDL region. This experiment followed collaborative work aiming to raise team awareness on task interruptions. Given the existing data in the literature, the investigators hypothesise that the implementation of a multifacet program focusing on interactions within a team could enable the percentage of task interruptions linked to interactions between coordination functions and healthcare provision activities to be decreased by 33%. This decrease would concern task interruptions that are avoidable, in order to improve healthcare safety and teamwork.

Also, the main objective of this project is to measure the impact of a program on the evolution of the characteristics of avoidable task interruptions. The project combines quantitative data (observations, questionnaire) and qualitative data (interviews).

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

This research is a controlled, randomised, blind, pragmatic intervention study (36 months). From the list of volunteering teams meeting inclusion criteria, a random selection will be made. This will enable the formation of two groups of 20 teams each (control group and experimental group). An observational method coupled with a validated questionnaire transfer will allow teams to be questioned about their avoidable task interruptions (control group and experimental group).

The multifacet intervention program is based the concept of teamwork implementation. Targeting potential for improvement will be decided and implemented by each team (experimental group).

Statistics analysis will be conducted on teams before and after the implementation of the program. The assessment criteria will be: the evolution of characteristics of the task interruptions observed (interactions between coordination functions and care delivery functions, prevalence, avoidability, duration, resumption of tasks, social representations of task interruptions).

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Nantes, France
        • CHU de Nantes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • volunteering healthcare teams from healthcare centres in the PDL region,
  • public and private legal statuses;
  • with at least one activity in standard medical and/or surgical hospitalisation unit,
  • agreeing to take part in the project,
  • formalising their commitment to the multifacet program (see section 4),
  • including 50 professionals at the most,
  • including at least the following professional categories: medical, paramedical, administrative, managerial and medical-technical/psycho-social.

Exclusion Criteria:

  • Healthcare teams who do not belong to a healthcare unit in the PDL region
  • Healthcare teams who do not work in a medical and/or surgical hospitalisation unit.
  • Paediatric healthcare teams
  • Teams that have already been subjected to a methodological support program from one of the co-investigating units on how to manage task interruptions,
  • Teams that do not meet the criteria for commitment to the multifacet program
  • Teams of more than 50 members
  • Teams who do not include the following professional categories: medical, paramedical, administrative, managerial, medical-technical/psycho-social.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 20 teams the first year (G1)
control group
Other: Identify work interruptions
estimate baseline characteristics of the collaborative working model (proportion expressed as a percentage)
Other: Understand work interruptions
Team-review of the results of the task interruption and professional representations, identify activities to protect from task interruption
Experimental: 20 teams second year (G2)
case group with implementation of the multi-unit team accompaniment intervention.
Other: Identify work interruptions
estimate baseline characteristics of the collaborative working model (proportion expressed as a percentage)
Other: Understand work interruptions
Team-review of the results of the task interruption and professional representations, identify activities to protect from task interruption
Other: Act to limited work interruptions
Adaptation of organizations; Awareness raising and Coaching for change

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
proportion of avoidable task interruptions
Time Frame: 1 year
Results from Dual Perspectives Method (DPM)
1 year
sources and frequencies of task interruptions
Time Frame: 1 year
Results from Auto-administered questionnaire (TAA-KH-S)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevalence of task interruptions
Time Frame: 1 year
Time measurement of the duration of task interruption upon restart of work
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nantes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2019

Primary Completion (Anticipated)

January 1, 2021

Study Completion (Anticipated)

January 1, 2022

Study Registration Dates

First Submitted

December 11, 2018

First Submitted That Met QC Criteria

December 20, 2018

First Posted (Actual)

December 26, 2018

Study Record Updates

Last Update Posted (Actual)

December 26, 2018

Last Update Submitted That Met QC Criteria

December 20, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • RC18_0047

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Identify work interruptions

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe